
A study emerging from St George’s University of London found that children who slept an hour less than the recommended …

A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …

This month has seen two new additions to Novo Nordisk’s Executive Management team. First of the pair is Camila Sylvest, …

Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …

Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of …

A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits …

Simon Williams, Head of Communications and Policy at Heart UK, discusses the threat posed by cholesterol in the development of …

NICE has dished out a double judgement turning down two drugs for advanced renal cell carcinoma, a form of kidney …

The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …

The FDA has launched an investigation after five deaths thought to be caused by an obesity treatment surgery in which …

Celgene has announced that it has chosen not to scoop up Sutro Biopharma, rejecting to take advantage of an option …

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …

Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …